Key Market Indicators
Sales of antidepressant medications in Latvia are expected to rise from $4.07 million in 2021 to nearly $4.5 million by 2026. This represents an average annual growth rate of 1.9%. Since 2006, the Latvian market has grown by an average of 7% each year. In 2021, Latvia was the 25th-largest market for antidepressants, behind Estonia, which had sales of $4.07 million. Germany, Spain and Italy ranked 2nd, 3rd and 4th, respectively.
